期刊文献+

血清软骨寡聚基质蛋白在幼年特发性关节炎中的临床意义 被引量:1

Serum cartilage oligomeric matrix protein in children with juvenile idiopathic arthritis and its clinical significance
下载PDF
导出
摘要 目的探讨血清软骨寡聚基质蛋白(COMP)在早期预测幼年特发性关节炎(JIA)关节破坏中的临床意义。方法采用ELISA法测定并对比分析35例幼年特发性关节炎患儿(JIA组)急性期、缓解期及30例腹股沟斜疝修补术儿童(对照组)血清COMP水平的差异,同时将血清COMP水平与JIA患儿的各项临床指标进行相关性分析。结果 JIA患儿急性期血清COMP水平(0.77±0.29)ng/ml,明显低于缓解期[(1.12±0.28)ng/ml]和对照组[(1.33±0.37)ng/ml],差异均有统计学意义(均P<0.05)。全身型JIA血清COMP水平(0.26±0.03)ng/ml,明显低于少关节型JIA[(0.87±0.17)ng/ml]、与附着点炎症相关型关节炎[(0.89±0.22)ng/ml]及多关节型JIA[(0.70±0.35)ng/ml],差异均有统计学意义(均P<0.05)。JIA中存在关节破坏的患儿血清COMP水平(0.52±0 22)ng/ml,明显低于无关节破坏患儿[(0.92±0.22)ng/ml],差异有统计学意义(P<0.05)。JIA患儿急性期血清COMP水平与WBC、CRP、ESR呈负相关(r=-0.556、-0.582、-0.684,均P<0.05),与关节压痛指数、关节肿胀指数、晨僵、血红蛋白、血小板无相关(r=0.06、-0.206、-0.107、-0.319、-0.185,均P>0.05)。结论血清COMP水平在JIA患儿急性期、全身型JIA、关节破坏JIA患儿中明显下降,与炎症指标CRP、ESR、WBC呈负相关,可能成为JIA疾病活动、关节破坏、生长抑制的预测指标。 Objective To evaluate the clinical significance of serum cartilage oligomeric matrix protein in early prediction of joint damage with juvenile idiopathic arthritis (JIA). Methods Serum cartilage oligomeric matrix protein (COMP) levels were measured by enzyme linked immunosorbent assay (ELISA) in 35 children with juvenile idiopathic arthritis (JIA) in acute phase or remission stage and 30 children with inguinal hernia (control group). The correlation of serum COMP levels with clinical indicators of JIA patients was analyzed. Results Serum COMP level of JIA children in acute phase (0.77 &#177; 0.29ng/ml) was significantly lower than that of control group (1.33± 0.37 ng/ml, P〈0.05). Serum COMP level of JIA children in acute phase was significantly lower than that in the recovery period (1.12±0.28ng/ml, P〈0.05). Serum COMP level of systemic JIA (0.26±0.03 ng/ml) was significantly lower than that of oligoarticular JIA (0.87± 0.17 ng/ml), enthesitis- related arthritis JIA (0.89± 0.22 ng/ml) and pol-yarticular JIA (0.70±0.35 ng/ml) (al P〈0.05). The serum COMP levels of JIA with joint damage(0.52±0.22ng/ml)was signifi-cantly lower than those without joint destruction (0.92±0.22ng/ml, P&lt;0.05). The serum COMP levels of JIA children in acute phase were negatively correlated with WBC, CRP, ESR (r=- 0.556,- 0.582,- 0.684, P〈0.05), not correlated with joint pain index, swel ing index, morning stiffness, hemoglobin, platelet(r=0.06,- 0.206,- 0.107,- 0.319,- 0.185, P〉0.05). Conclusion The lev-els of serum COMP are decreased in JIA with acute phase, systemic JIA and JIA with joint damage, and are negatively correlat-ed with inflammatory markers, indicating that serum COMP might be a useful predictor of JIA activity, joint destruction and growth inhibition.
出处 《浙江医学》 CAS 2014年第19期1601-1604,共4页 Zhejiang Medical Journal
基金 浙江省宁波市科技局科研项目(2010C50010) 浙江省宁波市卫生局科研项目(2009B03)
关键词 软骨寡聚基质蛋白 幼年特发性关节炎 关节破坏 Cartilage oligomeric matrix protein Juvenile idiopathic arthritis Joint damage
  • 相关文献

参考文献21

  • 1狄亚珍,吴菱,李蕴言,马田瑞.幼年特发性关节炎全身型反复发作患儿临床特点及治疗探讨[J].临床儿科杂志,2012,30(12):1128-1131. 被引量:4
  • 2Beukelman T, Patkar N M, Saag K G, et al, 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features[J]. Arthritis Care Res (Hoboken), 2011,63(4): 465-482.
  • 3杨洋,袁新宇.幼年特发性关节炎的影像学检查[J].中国医学影像技术,2012,28(10):1936-1939. 被引量:5
  • 4Verma P, Dalai K. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker[J]. J Orthop Res, 2013, 31(7): 999-1006.
  • 5Andersson M L, Svensson B, Petersson I F, et al. Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis[J], BMC Musculoskelet Disord. 2013.14: 229.
  • 6何晓琥.幼年特发性关节炎[J].中华风湿病学杂志,2002,6(1):62-63. 被引量:76
  • 7任晓碧,戴一希,谢敏叶.英夫利西单抗治疗幼年特发性关节炎不良反应的观察与护理[J].浙江医学,2013,35(18):1698-1699. 被引量:5
  • 8Stinson J N, Luca N J, Jibb L A. Assessment and management of pain in juvenile idiopathic arthritis[J]. Pain Res Manag, 2012,17(6): 391-396.
  • 9Laurell L, Court-Payen M, Boesen M, et al. Imaging in juvenile id- iopathic arthritis with a focus on ultrasonography[J]. Clin Exp Rheumatol, 2013, 31(1): 135-148.
  • 10Bender A L, da Silveira I G, von Muhlen C A, et al. High specificity but low sensitivity of the cartilage oligomeric matrix protein (COMP) test in rheumatoid arthritis and osteoarthritis[J]. Clin Chem Lab Med, 2010, 48(4): 569-570.

二级参考文献99

  • 1王淑兰,安东,杨志亮,姜红,罗钢.幼年特发性关节炎诊断分析及治疗新进展[J].中国实用儿科杂志,2005,20(10):579-584. 被引量:8
  • 2薛海燕,曹兰芳,马敏,卢燕鸣,毛海英,顾越英.激素治疗难治性全身型幼年特发性关节炎39例[J].实用儿科临床杂志,2007,22(9):678-679. 被引量:4
  • 3Fan K,Dai J,Wang H,et al.Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells[J].Arthritis Rheum,2008,58(7):2041-52.
  • 4Zheng W,Li R,Pan H,et al.Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis[J].Arthritis Rheum,2009,60(7):1957-65.
  • 5Uede T.Osteopontin,intrinsic tissue regulator of intractable inflammatory diseases[J].Pathol Int,2011,61(5):265-80.
  • 6Shinohara M L,Lu L,Bu J,et al.Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells[J].Nat Immunol,2006,7(5):498-506.
  • 7Shinohara M L,Kim H J,Kim J H,et al.Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells[J].Proc Natl Acad Sci USA,2008,105(20):7235-9.
  • 8Cantor H,Shinohara M L.Regulation of T-helper-cell lineage development by osteopontin:the inside story[J].Nat Rev Immunol,2009,9(2):137-41.
  • 9Shinohara M L,Kim J H,Garcia V A,et al.Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development:role of intracellular osteopontin[J].Immunity,2008,29(1):68-78.
  • 10Christensen B,Schack L,Klaning E,et al.Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D[J].J Biol Chem,2010,285(11):7929-37.

共引文献99

同被引文献22

  • 1Thierry S, Fautrel B, Lemelle I, et al. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review[J]. Joint Bone Spine, 2014, 81(2): 112-117.
  • 2Rittling S R, Singh R.Osteopontin in Immune-mediated Diseases [J]. J Dent Res, 2015,94(12): 1638-1645.
  • 3Su C M, Chiang Y C, Huang C Y, et al. Osteopontin Promotes On- costatin M Production in Human Osteoblasts: Implication of Rheumatoid Arthritis Therapy[J]. J Immunol, 2015, 195(7): 3355- 3364.
  • 4Catrina A I, Joshua V, Klareskog L, et al. Mechanisms involved in triggering rheumatoid arthritis[J]. Immunol Rev, 2016, 269(1): 162-174.
  • 5Beukelman T, Patkar N M, Saag K G, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features [J]. Arthritis Care Res (Hoboken), 2011,63(4): 465-482.
  • 6Amin R M, Miserocchi E, Thorne J E, et al. Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis[J]. Ocul Im- munol Inflamm, 2016,24(1):81-90.
  • 7Rigante D, Bosco A, Esposito S,The Etiology of Juvenile Idio- pathic Arthritis[J]. Clin Rev Allergy Immunol, 2015, 49(2): 253-261.
  • 8Ashkar S, Weber G F, Panoutsakopoulou V, et al. Eta-1 (osteo- pontin): an early component of type-1 (cell-mediated) immunity [J]. Science, 2000, 287(5454): 860-864.
  • 9Gonzalez-Chavez S A, Pacheco-Tena C, Macias-Vazquez C E, et aI.Assessment of different decalcifying protocols on Osteo- pontin and Osteocalcin immunostaining in whole bone speci- mens of arthritis rat model by confocal immunofluorescence[J]. Int J Clin Exp Pathol, 2013, 6(10): 1972-1983.
  • 10Subraman V, Thiyagarajan M, Malathi N, et aI.OPN -Revisited[J]. J Clin Diagn Res, 2015, 9(6): ZE10-13.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部